NIPC Law

Human Respiratory Syncytial Virus Author NIAID   Licence CC BY 2.0   Source    Wikimedia Commons   Jane Lambert Patents Court (Mr Justice Mellor)  Pfizer Ltd v GlaxoSmithKline Biologicals SA and another 2024] EWHC 2523 (Pat) (07 Oct 202 4) Pfizer Ltd v GlaxoSmithKline Biologicals SA and anothe r [2025] EWHC 52 (Pat) (16 Jan 2025) This was a claim by Pfizer Ltd. ("Pfizer")  for the revocation of  EP (UK) 3 109 258 ("258") and EP (UK) 2 222 710 ("710")  under s.72 (1) (a)  of the Patents Act 1977 on the grounds that the inventions for which those patents were granted were not patentable.  The patents were held by  GlaxoSmithKline Biologicals SA  and  ID Biomedical Corporation of Quebec  (collectively "GSK").   The reason for the litigation was that both Pfizer and GSK had developed vaccines for respiratory syncytial virus ("RSV")  that were about to receive marketing approval in the UK....

  Jane Lambert Intellectual Property Enterprise Court (HH Judge Hacon)  Battlekart Europe SA v Chaos Karts 1 Ltd and others [2025] EWHC 1936 (IPEC) (25 July 2025) This was an action by Battlekart Europe SA ("Battlekart") against Little Lion Entertainment Ltd ("Little Lion"), its subsidiaries, Chaos Karts Limited and The Ents Inc Limited and their director, Thomas Maguire for the infringement of European patent (UK) 3 304 522 B8  and a counterclaim by the defendants for revocation of the patent on grounds of obviousness , implausibility and added matter.   The action and counterclaim were tried by HH Judge Hacon between 17 and 19 June 2025.  By para [136] o f his judgment in Battlekart Europe SA v Chaos Karts 1 Ltd and others [2025] EWHC 1936 (IPEC), which he handed down on 25 July 2025, the learned judge held that the patent was invalid for lack of an inventive step and added matter. The Patent EP3304522 B8 had been granted for a system for creating an imm...

Author  Thirunavukkarasye-Raveendran   Licence CC BY- 4.0 Deed   Source Wikimedia Commons   Jane Lambert Patents Court (Mr Justice Mellor)  Abbott Diabetes Care Inc and others v Dexcom Incorporated and others   [2024] EWHC 36 (Pat) This was the first of three trials between Abbott Diabetes Care Inc. and its subsidiaries ("Abbott") and Dexcom Incorporated and its subsidiaries ("Dexcom") over patents owned by those companies in the field of continuous glucose monitoring ("CGM").  Abbott sued Dexcom for infringing  EP (UK) 2 146 627 ("EP627") entitled "Method and Apparatus for Providing Data Processing and Control in Medical Communication System"  and  EP (UK) 2 476 223 ("EP223") entitled "Methods and Articles of Manufacture for Hosting a Safety Critical Application on an Uncontrolled Data Processing Device ". Dexcom counterclaimed for revocation of both patents on grounds of lack of novelty  and inventive step and in...